Among individuals with gastroesophageal reflux disease (GERD), a negative upper endoscopy is associated with decreased risk in incidence and mortality from gastrointestinal cancer. The benefit ...

Nat Clin Pract Gastroenterol Hepatol. 2006;3(10):534-535. When considering the value of early endoscopy in upper gastrointestinal bleeding, we must first examine the overall value of endoscopy in this ...

The American College of Physicians Clinical Guidelines Committee has released a new evidence-based clinical policy paper revising the guidelines for upper endoscopy use in most patients. During the ...

Administering a lidocaine lollipop as a single-agent anesthetic to patients undergoing an upper gastrointestinal endoscopy procedure eliminated the need for sedation in the majority of patients. Upper ...

Members of the medical community, certain medical device manufacturers and government regulatory agencies are allowing patients to spend an extra $15 billion dollars a year by allowing unnecessary, ...

Here are the 2010 CMS reimbursement rates for five GERD-related upper endoscopy procedures in the ASC setting. 1. Esophagoscopy, rigid or flexible; diagnostic, with or without collection of specimen(s ...

Despite advances in our knowledge of celiac disease, the most current and authoritative recommendations conclude that diagnosis requires at least four biopsy specimens to be taken from the duodenal ...

Use upper endoscopy wisely Inappropriate endoscopy use generates unnecessary costs and exposes patients to harms without improving outcomes. Although upper endoscopy is commonly used in the diagnosis ...

Doctors may perform an upper gastrointestinal endoscopy to diagnose and help treat stomach ulcers. During the procedure, a healthcare professional inserts an endoscope through the mouth and into the ...

For GI clinics and ASCs, accurate coding and documentation are critical to protecting reimbursement, reducing denials and ...

Please provide your email address to receive an email when new articles are posted on . Younger age, tirzepatide and oral semaglutide were associated with a higher risk for retained gastric contents.